Tetra Bio Pharma Announces Commercialization Strategy
Tetra Bio Pharma (TSXV: TBP) released information on its commercialization effort this morning related to two products that received Health Canada approval last week. The company has selected a contract manufacturer for both products, which is expected to begin manufacturing in the upcoming weeks. The manufacturer is to produce both Terpacan Back and Muscle Pain, […]
Ravenquest Latest Cannabis Firm To Conduct Layoffs As Cash Runs Thin
Ravenquest Biomed (CSE: RQB) has cut staff and reduced expenditures as it becomes the latest public cannabis issuer to attempt to conserve cash as funds run dry. The company announced Friday after hours that they had made “significant reductions in staffing” although specifics were not provided. The reductions in staffing comes days after the company […]
Tetra Bio Pharma Sees Two Products Approved By Health Canada
As The Deep Dive reported on late yesterday afternoon, Tetra Bio Pharma (TSXV: TBP) has received approval from Health Canada for over the counter products. The catch, is that the company has actually received approval for two separate products from the regulator. Both products are to be marketed under the Terpacan banner. The products, referred […]
Hexo Corp Returns To Trough For Further US$20 Million Funding
Hexo Corp (TSX: HEXO) (NYSE: HEXO) this morning announced its second financing of the month, this time for US$20.0 million. The terms appear to be substantially the same as the registered direct offering announced in late December and closed at the start of January. Under the terms of the registered direct offering announced this morning, […]
PharmaCielo Receives Approval For US$3 Million Import Contract
PharmaCielo Ltd (TSXV: PCLO) has become one of the first venture listed equities to receive approval for the importation of cannabidiol isolate to the United States. The company announced this morning that the exchange has finally granted the approval, which will allow the company to fulfill its previously announced supply agreement. The supply agreement, announced […]
Canopy Growth Delays Cannabis Beverages Due To Production Issues
It appears that having all the money in the world can’t solve quite everything. Canopy Growth Corp (TSX: WEED) (NYSE: CGC), the current cannabis sector leader in terms of size and funding announced this morning that the company will be delaying its roll out of its cannabis beverage product line, despite previous announcements. The news […]
Village Farms Requests $5.94 Million Refund From Pure Sunfarms
It appears that Village Farms (TSX: VFF) (NASDAQ: VFF) is taking a step back from the battle it began with Emerald Therapeutics (TSXV: EMH) back in November 2019. The company announced this morning that it had opted to see its $5.94 million returned that it advanced in November as it attempted to stake a majority […]
Tetra Bio Pharma Sees Drug Approved By Health Canada
Tetra Bio Pharma (TSXV: TBP) is currently seeing upward price momentum on the discovery that one of its products appears to have been approved by Health Canada. The online Health Canada products database has listed one of the company’s products as “approved,” with the status change date being listed as January 15, 2020. The product […]
Market Movers: Bombardier Tumbles After Failing To Meet Revised Guidance
Bombardier Inc’s Class B Subordinate Shares (TSX: BBD.B) has been the largest marker mover by volume on the TSX today following the company revising guidance downward for the third time this fiscal year. Investors have reacted hard to the revised guidance, with shares of the equity currently trading down 30% on the TSX, at $1.25 […]
Meta Growth Sees Sale Of Medical Division Fall Through
It appears the divestment of Meta Growth’s (TSXV: META) non-core assets won’t be proceeding as previously stated. The company issued a late night news release last night, identifying that the transaction with Evergreen Pacific Insurance Corporation had fallen through and would be terminated effective immediately. Originally, Meta Growth was to sell its medical cannabis clinics […]